Neuropeptides in Cancer: Friend and Foe?

Neuropeptides are small regulatory molecules found throughout the body, most notably in the nervous, cardiovascular, and gastrointestinal systems. They serve as neurotransmitters or hormones in the regulation of diverse physiological processes. Cancer cells escape normal growth control mechanisms by altering their expression of growth factors, receptors, or intracellular signals, and neuropeptides have recently been recognized as mitogens in cancer growth and development. Many neuropeptides and their receptors exist in multiple subtypes, coupling with different downstream signaling pathways and playing distinct roles in cancer progression. The consideration of neuropeptide/receptor systems as anticancer targets is already leading to new biological and diagnostic knowledge that has the potential to enhance the understanding and treatment of cancer. In this review, recent discoveries regarding neuropeptides in a wide range of cancers, emphasizing their mechanisms of action, signaling cascades, regulation, and therapeutic potential, are discussed. Current technologies used to manipulate and analyze neuropeptides/receptors are described. Applications of neuropeptide analogs and their receptor inhibitors in translational studies and radiooncology are rapidly increasing, and the possibility for their integration into therapeutic trials and clinical treatment appears promising.

Automated summary

Neuropeptides, small regulatory molecules found throughout the body, have been recognized as mitogens in cancer growth and development. They play important roles in the regulation of diverse physiological processes and their study has the potential to enhance the understanding and treatment of cancer. The mechanisms of action, signaling cascades, and therapeutic potential of neuropeptides in a wide range of cancers are discussed in this review.